ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 215 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $822,000 | -64.4% | 20,341 | -49.4% | 0.01% | -58.3% |
| Q2 2015 | $2,312,000 | +44.3% | 40,173 | -13.6% | 0.01% | -14.3% |
| Q2 2014 | $1,602,000 | -3.7% | 46,512 | +20.8% | 0.01% | -12.5% |
| Q1 2014 | $1,663,000 | +355.6% | 38,492 | +320.3% | 0.02% | +700.0% |
| Q4 2013 | $365,000 | -24.9% | 9,159 | -49.4% | 0.00% | -60.0% |
| Q2 2013 | $486,000 | – | 18,092 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crosspoint Capital Strategies, LLC | 600 | $37,000 | 0.01% |
| PRENTISS SMITH & CO INC | 200 | $12,000 | 0.01% |
| MARSHALL & SULLIVAN INC /WA/ | 100 | $4,000 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 0 | $0 | 0.00% |